Standard BioTools Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on LAB yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Standard BioTools stockholders approved all proposals tied to its merger with Treeline Biosciences and the sale of its Mass Cytometry business to Element Biosystems, an acquisition vehicle formed by GMT Venture Partners. The company announced the vote results itself, so the approvals are on the record.
No SEC financials for LAB yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.